Position in NVS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$656,813
+$5,335 QoQ
Shares Held
4,191
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#772
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESBANCO BANK INC holds $195,633,177 across 11 Drug Manufacturers - General names. NVS ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,820 | $38,165,865 | |
| 2 | JNJ |
Johnson & Johnson
|
149,930 | $38,077,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
280,575 | $36,053,887 | |
| 4 | AMGN |
Amgen Inc
|
88,377 | $32,003,078 | |
| 5 | ABBV |
AbbVie Inc.
|
75,720 | $19,054,180 | |
| 6 | AZN |
Astrazeneca PLC
|
68,209 | $12,933,789 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
217,215 | $12,515,927 | |
| 8 | PFE |
Pfizer Inc
|
162,515 | $3,913,360 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,813 | 4,191 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $651,478 | 4,265 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $461,864 | 3,350 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $451,917 | 3,524 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $443,380 | 3,664 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $408,462 | 3,664 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $356,543 | 3,664 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $468,016 | 4,069 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $436,378 | 4,099 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $439,541 | 4,544 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $392,974 | 3,892 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $471,917 | 4,633 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $467,515 | 4,633 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $439,576 | 4,778 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $453,962 | 5,004 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $319,013 | 4,197 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $435,160 | 5,148 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $475,078 | 5,414 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $473,562 | 5,414 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $497,304 | 6,081 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $620,158 | 6,797 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $506,553 | 5,926 | Shares | Sole | 2021-05-06 | |
| 2020-09-30 | $608,980 | 7,003 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $616,882 | 7,063 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $587,703 | 7,128 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||